Page last updated: 2024-10-15

dinitrochlorobenzene and Carcinoma, Transitional Cell

dinitrochlorobenzene has been researched along with Carcinoma, Transitional Cell in 10 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer."9.04Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978)
"Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer."9.04Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)
"Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum."6.64Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)
"Tumor recurrence seems to be rare in those patients who are initially DNCB-positive."6.64Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)
"We have done a double-blind, randomized, controlled study on 37 patients with transitional cell carcinoma in which levamisole was used as an immune adjuvant in addition to the standard therapy for non-invasive and invasive bladder cancer."5.04Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. ( Baron, B; Dekernion, J; Kaufman, JJ; Skinner, DG; Smith, RB, 1978)
"Sixty-two patients with transitional cell carcinoma have been admitted to a double-blind randomized control study with levamisole as an immune adjuvant, in addition to standard therapy for noninvasive and invasive bladder cancer."5.04Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)
"Levamisole has been shown to be easily administered and is well-tolerated, especially when compared to other immune adjuvants such as bacillus Calmette-Guerin or Corynebacterium parvum."2.64Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)
"Tumor recurrence seems to be rare in those patients who are initially DNCB-positive."2.64Preliminary report of the use of levamisole in the treatment of bladder cancer. ( deKernion, J; Kaufman, JJ; Lincoln, B; Skinner, DG; Smith, RB, 1978)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19909 (90.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simic, T1
Mimic-Oka, J1
Savic-Radojevic, A1
Opacic, M1
Pljesa, M1
Dragicevic, D1
Djokic, M1
Radosavljevic, R1
Jakse, G1
Hofstädter, F1
Märk, R1
Johnson, DK1
Pontes, JE1
Izbicki, R1
Pierce, JM1
Bean, MA1
Schellhammer, PS1
Herr, HW1
Pinsky, CM1
Whitmore, WF1
Smith, RB2
Dekernion, J2
Baron, B1
Skinner, DG2
Kaufman, JJ2
Lincoln, B1
Adolphs, HD2
Steffens, L2
Fahey, JL1
Brosman, S1
Dorey, F1
Catalona, WJ1
Smolev, JK1
Harty, JI1

Trials

2 trials available for dinitrochlorobenzene and Carcinoma, Transitional Cell

ArticleYear
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
    The Journal of urology, 1978, Volume: 119, Issue:3

    Topics: Aged; Antigens, Neoplasm; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as To

1978
Preliminary report of the use of levamisole in the treatment of bladder cancer.
    Cancer treatment reports, 1978, Volume: 62, Issue:11

    Topics: Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Clinical Trials as Topic; Dinitrochlorobenzene;

1978

Other Studies

8 other studies available for dinitrochlorobenzene and Carcinoma, Transitional Cell

ArticleYear
Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder.
    Urology, 2005, Volume: 65, Issue:5

    Topics: Carcinoma, Transitional Cell; Dinitrochlorobenzene; Glutathione Transferase; Humans; Substrate Speci

2005
Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
    Urologia internationalis, 1981, Volume: 36, Issue:3

    Topics: Aged; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Dinitrochlorobenzene;

1981
Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.
    Urological research, 1980, Volume: 8, Issue:1

    Topics: Administration, Topical; Animals; Carcinoma, Transitional Cell; Dinitrochlorobenzene; FANFT; Female;

1980
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    National Cancer Institute monograph, 1978, Issue:49

    Topics: Carcinoma, Transitional Cell; Concanavalin A; Dinitrochlorobenzene; Humans; In Vitro Techniques; Lym

1978
Correlation between tumour stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate.
    European urology, 1977, Volume: 3, Issue:1

    Topics: Adenocarcinoma; Antibody Formation; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Female; Huma

1977
Evaluation of the immunocompetance of patients with transitional cell carcinoma of the bladder.
    Urological research, 1977, Volume: 5, Issue:1

    Topics: Adult; Aged; Antibody Formation; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Drug Hypersensi

1977
Immunological responsiveness in patients with bladder cancer.
    Cancer research, 1977, Volume: 37, Issue:8 Pt 2

    Topics: Antigens; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Imm

1977
Prognostic value of host immunocompetence in urologic cancer patients.
    The Journal of urology, 1975, Volume: 114, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Female; Follow-Up S

1975